Oncolytic virus therapy: A new era of cancer treatment at dawn
about
Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer AscitesOncolytic virotherapy including Rigvir and standard therapies in malignant melanoma.Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China.Advancing Cancer Therapy with Present and Emerging Immuno-Oncology ApproachesCurrent status of clinical trials assessing oncolytic virus therapy for urological cancers.Tackling non-muscle invasive bladder cancer in the clinic.Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model.Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models.EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.Imaging Manifestations of Pseudoprogression in Metastatic Melanoma Nodes Injected with Talimogene Laherparepvec: Initial Experience.Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells.Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate CancerTargeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein.Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12-13 May 2017.Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma.Challenges and opportunities in bioanalytical support for gene therapy medicinal product development.Alternative therapies in patients with non-muscle invasive bladder cancer.Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells.ELAS1 induces apoptotic death in adenocarcinoma DU145 and squamous-cell carcinoma SAS cancer cells, but not in normal KD cells.Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA Damaging Agents: Implications for Oncolytic Virus Therapy.Transcriptional retargeting of herpes simplex virus for cell-specific replication to control cancer.A third-generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice.Thyroid dysfunctions secondary to cancer immunotherapy.Cancer stem cells, the ultimate targets in cancer therapy.The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy.Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells.Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models.Current Strategies to Enhance Anti-Tumour Immunity.Immunotherapy for Breast Cancer: Current and Future Strategies.Advances in the mechanisms of action of cancer-targeting oncolytic viruses.Bladder cancer.The Host Factor Early Growth Response Gene (EGR-1) Regulates Vaccinia virus Infectivity during Infection of Starved Mouse Cells.Haliotis discus discus Sialic Acid-Binding Lectin Reduces the Oncolytic Vaccinia Virus Induced Toxicity in a Glioblastoma Mouse Model.Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review.Viral Vectors in Gene Therapy.Oncolytic Viruses as Therapeutic Tools for Pediatric Brain TumorsHerpes simplex virus type 1 infection promotes the growth of a subpopulation of tumor cells in 3D uveal melanoma cultures
P2860
Q33904378-74DCC020-6407-4F42-822C-95E595CE3860Q37641495-D33436A2-E777-4DDF-9712-DDD2D2521E0FQ37724094-06519220-6AA3-434A-958C-6DA0EA8FF128Q38689153-AC026419-08AC-47B3-A7AD-AAEFF3A9C825Q38741837-CC59DED7-C6EB-4ABF-8110-09501563AA92Q39209020-688BFB60-83E7-48E5-94DD-A55ECB752878Q40056618-0B45C308-759C-4EB6-9595-F754A6429835Q40064004-67CBD487-5364-4EA6-A807-FBE7CEE6EE91Q40089704-BD7C27F3-6C2F-4B9D-AABB-318629C662C2Q40233749-5488402D-B9E4-473F-88D8-0C783E95F155Q41688010-46B95559-362C-44E3-B9DD-69200B8EC844Q41699675-4F99B1A1-E027-4BA3-B7FB-18B63BBD978CQ41919532-F30289C5-D7C2-4E17-907A-97A6C827A210Q41976096-7A3071E4-4562-4AB7-8D8E-1C4EDB3EED53Q42336210-64DFAF5D-D5E0-4B8D-9D24-EA1E74114D62Q45121629-2196D9FA-29BD-452D-BFB1-D781EDBEE82BQ45872061-895FA2CD-FA1C-4C64-BD8F-589C14797F1DQ47114392-05FD5576-3DDF-4018-AC8C-D43B388F73B2Q47132045-0637638D-E190-411F-A477-52AFFBFCCC70Q47141743-3A6EE077-3225-4594-B052-B407DC9EAC1DQ47552296-03B9B9ED-D3B7-4C69-92AF-FD20B74A23B5Q47557634-8BBEA3F6-465D-4836-94FE-3D7F7B3E0E45Q47559554-A1315F02-3F9D-47F0-A91D-968865491B3BQ47565857-29220138-0035-4C30-B122-008A9994A456Q47643497-61B50AB9-10D5-44C6-831B-A984F30E4E50Q49463699-09AD21C2-5842-4FFE-ABD1-D867970C14FFQ49959107-2CC2C171-74DD-416B-A8E4-DEC6F729EF20Q50056861-480E0F57-2206-4130-8F9C-BB335CA51151Q50128059-8D82854A-4130-49A6-9B17-5B743B447986Q52337612-1B2CDE55-D43A-4DA8-8B87-EA671D3373E7Q52344613-C8E3856F-C4A1-4ACD-9E08-1D3721A0565DQ52587066-D85F7DC3-2F63-4331-AE85-0D3FA50209ECQ52655195-EE976153-7DBE-4414-A3DD-AB31C07C1A88Q52810295-924323D0-47FF-4099-B6A8-0229AB2C23E9Q54120212-33873B98-BFAF-4473-B912-87B31BE360FBQ54980119-10346BB3-60FE-4395-8C87-294187B80DC1Q55268879-B04DF380-56C6-4990-B987-C75095E80CE9Q55408780-47E3663D-081D-4CB6-AFF2-2B6F0587035EQ56892727-1F60743C-1DF9-417E-A96B-33556278C8A9Q57022066-A92D0D55-AB18-4944-B006-B452401A251F
P2860
Oncolytic virus therapy: A new era of cancer treatment at dawn
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Oncolytic virus therapy: A new era of cancer treatment at dawn
@ast
Oncolytic virus therapy: A new era of cancer treatment at dawn
@en
Oncolytic virus therapy: A new era of cancer treatment at dawn
@nl
type
label
Oncolytic virus therapy: A new era of cancer treatment at dawn
@ast
Oncolytic virus therapy: A new era of cancer treatment at dawn
@en
Oncolytic virus therapy: A new era of cancer treatment at dawn
@nl
prefLabel
Oncolytic virus therapy: A new era of cancer treatment at dawn
@ast
Oncolytic virus therapy: A new era of cancer treatment at dawn
@en
Oncolytic virus therapy: A new era of cancer treatment at dawn
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Oncolytic virus therapy: A new era of cancer treatment at dawn
@en
P2093
Hiroshi Fukuhara
Tomoki Todo
Yasushi Ino
P2860
P3181
P356
10.1111/CAS.13027
P5008
P577
2016-08-03T00:00:00Z
2016-10-01T00:00:00Z